Message from the Office of the Comptroller and Office of Research and Innovation
Dear Drexel Research Community,
NIH recently issued NOT-OD-26-072, which has generated questions about whether NIH indirect cost rules have changed again—and whether this creates an adverse impact for Drexel investigators.
To support the community in navigating these updates, we’ve developed an FAQ to help address common questions and offer further clarification.
The major changes to be noted:
- 15% NIH indirect cost cap is not in effect.
- The $50K threshold for NIH subawards has been rescinded. The $25K threshold for NIH subawards remains.
- Please refer to the NOA for all other sponsors regarding these issues. The NOA for each award will dictate the treatment of these issues.
Overall, for NIH grants, none of the recently announced “expanded” indirect cost flexibilities ultimately apply—NIH has reverted to the prior indirect cost framework, and Drexel should continue budgeting NIH awards accordingly.
Thank you,
Patricia J. Dalessandro, MBA, CPA, CFE
Vice President and Comptroller
Office of the Comptroller
Aleister J. Saunders, Ph.D.
Executive Vice Provost for Research & Innovation
Office of Research & Innovation
This announcement can also be found on the Comptroller website